The Effect of Depressive Symptoms on Adherence to Daily Oral PrEP in Men who have Sex with Men and Transgender Women: A Marginal Structural Model Analysis of The iPrEx OLE Study (original) (raw)

References

  1. Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010;363(27):2587–99.
    Article CAS PubMed PubMed Central Google Scholar
  2. Baeten JM, Donnell D, Ndase P, Mugo NR, Campbell JD, Wangisi J, et al. Antiretroviral prophylaxis for HIV-1 prevention among heterosexual men and women. N Engl J Med. 2012;367(5):399–410.
    Article CAS PubMed PubMed Central Google Scholar
  3. Choopanya K, Martin M, Suntharasamai P, Sangkum U, Mock PA, Leethochawalit M, et al. Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial. The Lancet. 2013;381(9883):2083–90.
    Article Google Scholar
  4. Marrazzo JM, Ramjee G, Richardson BA, Gomez K, Mgodi N, Nair G, et al. Tenofovir-based preexposure prophylaxis for hiv infection among african women. N Engl J Med. 2015;372(6):509–18.
    Article PubMed PubMed Central Google Scholar
  5. Thigpen MC, Kebaabetswe PM, Paxton LA, Smith DK, Rose CE, Segolodi TM, et al. Antiretroviral preexposure prophylaxis for heterosexual hiv transmission in botswana. N Engl J Med. 2012;367(5):423–34.
    Article CAS PubMed Google Scholar
  6. Van Damme L, Corneli A, Ahmed K, Agot K, Lombaard J, Kapiga S, et al. Preexposure prophylaxis for hiv infection among african women. N Engl J Med. 2012;367(5):411–22.
    Article PubMed PubMed Central Google Scholar
  7. Anderson PL, Glidden DV, Liu A, Buchbinder S, Lama JR, Guanira JV, et al. Emtricitabine–tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men. Sci Transl Med. 2012;4(151):151ra125–151ra125.
    Article PubMed PubMed Central Google Scholar
  8. Commissioner O of the. Press Announcements–FDA approves first drug for reducing the risk of sexually acquired HIV infection [Internet]. [cited 2015 Aug 17]. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm312210.htm.
  9. Corneli AL, Deese J, Wang M, Taylor D, Ahmed K, Agot K, et al. FEM-PrEP: adherence patterns and factors associated with adherence to a daily oral study product for pre-exposure prophylaxis. J Acquir Immune Defic Syndr. 2014;66(3):324–31.
    Article CAS PubMed PubMed Central Google Scholar
  10. Grant RM, Anderson PL, McMahan V, Liu A, Amico KR, Mehrotra M, et al. Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study. Lancet Infect Dis. 2014;14(9):820–9.
    Article PubMed Google Scholar
  11. Deutsch MB, Glidden DV, Sevelius J, Keatley J, McMahan V, Guanira J, et al. HIV pre-exposure prophylaxis in transgender women: a subgroup analysis of the iPrEx trial. Lancet HIV [Internet]. 2015 Nov [cited 2015 Nov 9]; Available from: http://linkinghub.elsevier.com/retrieve/pii/S2352301815002064.
  12. Haberer JE, Bangsberg DR, Baeten JM, Curran K, Koechlin F, Amico KR, et al. Defining success with HIV pre-exposure prophylaxis: a prevention-effective adherence paradigm. AIDS Lond Engl. 2015;29(11):1277–85.
    Article Google Scholar
  13. Cochran SD, Mays VM, Sullivan JG. Prevalence of mental disorders, psychological distress, and mental health services use among lesbian, gay, and bisexual adults in the United States. J Consult Clin Psychol. 2003;71(1):53–61.
    Article PubMed PubMed Central Google Scholar
  14. Hoffman B. An overview of depression among transgender women. Depress Res Treat. 2014;13(2014):e394283.
    Google Scholar
  15. Safren SA, O’Cleirigh C, Tan JY, Raminani SR, Reilly LC, Otto MW, et al. A randomized controlled trial of cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected individuals. Health Psychol Off J Div Health Psychol Am Psychol Assoc. 2009;28(1):1–10.
    Google Scholar
  16. Hatzenbuehler ML, O’Cleirigh C, Mayer KH, Mimiaga MJ, Safren SA. Prospective associations between HIV-related stigma, transmission risk behaviors, and adverse mental health outcomes in men who have sex with men. Ann Behav Med Publ Soc Behav Med. 2011;42(2):227–34.
    Article Google Scholar
  17. O’Cleirigh C, Skeer M, Mayer KH, Safren SA. Functional impairment and health care utilization among HIV-infected men who have sex with men: the relationship with depression and post-traumatic stress. J Behav Med. 2009;32(5):466–77.
    Article PubMed PubMed Central Google Scholar
  18. Mays VM, Cochran SD. Mental health correlates of perceived discrimination among lesbian, gay, and bisexual adults in the United States. Am J Public Health. 2001;91(11):1869–76.
    Article CAS PubMed PubMed Central Google Scholar
  19. Lin EHB, Katon W, Von Korff M, Rutter C, Simon GE, Oliver M, et al. Relationship of depression and diabetes self-care, medication adherence, and preventive care. Diabetes Care. 2004;27(9):2154–60.
    Article PubMed Google Scholar
  20. Koblin BA, Husnik MJ, Colfax G, Huang Y, Madison M, Mayer K, et al. Risk factors for HIV infection among men who have sex with men: AIDS. 2006;20(5):731–9.
    PubMed Google Scholar
  21. Salomon EA, Mimiaga MJ, Husnik MJ, Welles SL, Manseau MW, Montenegro AB, et al. Depressive symptoms, utilization of mental health care, substance use and sexual risk among young men who have sex with men in EXPLORE: implications for age-specific interventions. AIDS Behav. 2009;13(4):811–21.
    Article PubMed Google Scholar
  22. Prentice RL. A case-cohort design for epidemiologic cohort studies and disease prevention trials. Biometrika. 1986;73(1):1–11.
    Article Google Scholar
  23. Castillo-Mancilla JR, Zheng J-H, Rower JE, Meditz A, Gardner EM, Predhomme J, et al. Tenofovir, emtricitabine, and tenofovir diphosphate in dried blood spots for determining recent and cumulative drug exposure. AIDS Res Hum Retroviruses. 2013;29(2):384–90.
    CAS PubMed PubMed Central Google Scholar
  24. Crockett LJ, Randall BA, Shen YL, Russell ST, Driscoll AK. Measurement equivalence of the center for epidemiological studies depression scale for Latino and Anglo adolescents: a national study. J Consult Clin Psychol. 2005;73(1):47–58.
    Article PubMed Google Scholar
  25. Radloff LS. The CES-D Scale A self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1(3):385–401.
    Article Google Scholar
  26. Ruiz-Grosso P, Loret de Mola C, Vega-Dienstmaier JM, Arevalo JM, Chavez K, Vilela A, et al. Validation of the spanish center for epidemiological studies depression and zung self-rating depression scales: a comparative validation study. PLoS ONE. 2012;7(10):e45413.
    Article CAS PubMed PubMed Central Google Scholar
  27. Reuland DS, Cherrington A, Watkins GS, Bradford DW, Blanco RA, Gaynes BN. Diagnostic Accuracy of Spanish Language Depression-Screening Instruments. Ann Fam Med. 2009;7(5):455–62.
    Article PubMed PubMed Central Google Scholar
  28. Vatanasin D, Thapinta D, Thompson EA, Thungjaroenkul P. Testing a model of depression among thai adolescents. J Child Adolesc Psychiatr Nurs. 2012;25(4):195–206.
    Article PubMed Google Scholar
  29. Lewinsohn PM, Rohde P, Seeley JR. Adolescent suicidal ideation and attempts: prevalence, risk factors, and clinical implications. Clin Psychol Sci Pract. 1996;3(1):25–46.
    Article Google Scholar
  30. Orme JG, Reis J, Herz EJ. Factorial and discriminant validity of the center for epidemiological studies depression (CES-D) scale. J Clin Psychol. 1986;42(1):28–33.
    Article CAS PubMed Google Scholar
  31. Greenland S, Pearl J, Robins JM. Causal diagrams for epidemiologic research. Epidemiology. 1999;10(1):37–48.
    Article CAS PubMed Google Scholar
  32. Robins JM, Hernán MA, Brumback B. Marginal structural models and causal inference in epidemiology. Epidemiol Camb Mass. 2000;11(5):550–60.
    Article CAS Google Scholar
  33. Fewell Z, Hernán MA, Wolfe F, Tilling K, Choi H, Sterne JA. Controlling for time-dependent confounding using marginal structural models. Stata J. 2004;4(4):402–20.
    Google Scholar
  34. Cole SR, Hernán MA. Constructing inverse probability weights for marginal structural models. Am J Epidemiol. 2008;168(6):656–64.
    Article PubMed PubMed Central Google Scholar
  35. VanderWeele TJ, Knol MJ. A Tutorial on Interaction. Epidemiol Methods [Internet]. 2014. [cited 2015 Aug 18];3(1). http://www.degruyter.com/view/j/em.2014.3.issue-1/em-2013-0005/em-2013-0005.xml.
  36. STATA Statistical Software: Release 13. College Station, TX: StataCorp LP.
  37. Roberts RE, Rhoades HM, Vernon SW. Using the CES-D scale to screen for depression and anxiety: Effects of language and ethnic status. Psychiatry Res. 1990;31(1):69–83.
    Article CAS PubMed Google Scholar
  38. Campos LN, Guimarães MDC, Remien RH. Anxiety and depression symptoms as risk factors for non-adherence to antiretroviral therapy in Brazil. AIDS Behav. 2010;14(2):289–99.
    Article PubMed Google Scholar
  39. Nel A, Kagee A. The relationship between depression, anxiety and medication adherence among patients receiving antiretroviral treatment in South Africa. AIDS Care. 2013;25(8):948–55.
    Article PubMed Google Scholar
  40. Beck AT, Steer RA, Carbin MG. Psychometric properties of the beck depression inventory: twenty-five years of evaluation. Clin Psychol Rev. 1988;8(1):77–100.
    Article Google Scholar
  41. Defechereux P, Mehrotra M, Liu A, McMahan V, Glidden D, Mayer K, et al. Depression and oral ftc/tdf pre-exposure prophylaxis (prep) among men and transgender women who have sex with men (msm/tgw). AIDS Behav. 2015;16:1–11.
    Google Scholar

Download references